Sue Schneider, PhD, RN, AOCN, ACNS-BC, FAAN, associate professor at Duke University School of Nursing (DUSON) was recently appointed to the Biden Cancer Initiative board of directors, along with other experts in healthcare, business, finance and technology. As president of the Oncology Nursing Society (ONS) and faculty lead for oncology education at DUSON, Schneider is perfectly poised to lend her expertise to this national initiative.
“Improving healthcare delivery systems, care coordination and enhancing the patient experience are key ways to advance cancer care,” says Schneider. “As the only nurse on the Biden Cancer initiative Board of Directors, I will share my nursing expertise in symptom management and advanced practice nursing to accelerate progress in cancer care. I’ll continue to use my experience as an ONS leader to advocate for quality cancer care for all patients.”
Schneider serves at DUSON as the faculty lead for the oncology specialty and has extensive experience in pediatric and adult oncology nursing. Schneider’s research interests include management of symptom distress in cancer patients, the use of distraction interventions to enhance coping and the use of tailored protocols to promote chemotherapy adherence.
“The Duke University School of Nursing community is proud of Dr. Schneider and her appointment to the board of the Biden Cancer Institute,” says Marion E. Broome, PhD, RN, FAAN, Duke University School of Nursing dean and Ruby Wilson Professor of Nursing, vice chancellor for Nursing Affairs at Duke University and associate vice president for Academic Affairs for Nursing at Duke University Health System. “Dr. Schneider’s commitment to oncology nursing and patient care continues to be seen nationally and we’re proud of the work she’s doing.”
The Biden Cancer Initiative develops and drives implementation of solutions to accelerate progress in cancer prevention detection, diagnosis, research and care and to reduce disparities in cancer outcomes. The Initiative is led by esteemed leaders and experts in the fields of medical research, patient care, information technology, finance, management, patient engagement, patient experience and public policy.
The Initiative works closely with patients and patient organizations, cancer researchers, cancer centers, research universities, governments and the private and philanthropic sectors to identify and address the critical issues in cancer prevention, research and care to drive new actions and collaborations toward ending cancer as we know it today.
“Every single day, oncology nurses lead by example. They provide exceptional, expert care; participate in and drive research; and most importantly, give patients and their families reasons to hope and persevere against many odds,” says Greg Simon, President, Biden Cancer Initiative. “We know that the perspectives and expertise we will be getting from Dr. Schneider will make a meaningful difference in the work of the Initiative.”
The Biden Cancer Initiative’s mission is to develop and drive implementation of solutions to accelerate progress in cancer prevention, detection, diagnosis, research, and care, and to reduce disparities in cancer outcomes. If you have a personal experience and would like to connect with the Biden Cancer Initiative, use hashtag #cancerFIERCE.